Free Trial
NASDAQ:SXTC

China SXT Pharmaceuticals (SXTC) Stock Price, News & Analysis

China SXT Pharmaceuticals logo
$2.44 -0.13 (-5.06%)
Closing price 04/3/2025 03:55 PM Eastern
Extended Trading
$2.40 -0.04 (-1.43%)
As of 08:06 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About China SXT Pharmaceuticals Stock (NASDAQ:SXTC)

Key Stats

Today's Range
$2.41
$2.52
50-Day Range
$2.44
$6.72
52-Week Range
$2.40
$26.96
Volume
13,487 shs
Average Volume
122,991 shs
Market Capitalization
$1.76 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company had an end-customer base of pharmaceutical companies, chain pharmacies, and hospitals in 10 provinces and municipalities in China. China SXT Pharmaceuticals, Inc. was founded in 2005 and is headquartered in Taizhou, China.

Remove Ads

China SXT Pharmaceuticals Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
9th Percentile Overall Score

SXTC MarketRank™: 

China SXT Pharmaceuticals scored higher than 9% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for China SXT Pharmaceuticals.

  • Price to Book Value per Share Ratio

    China SXT Pharmaceuticals has a P/B Ratio of 0.08. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    0.24% of the float of China SXT Pharmaceuticals has been sold short.
  • Short Interest Ratio / Days to Cover

    China SXT Pharmaceuticals has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in China SXT Pharmaceuticals has recently decreased by 54.81%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    China SXT Pharmaceuticals does not currently pay a dividend.

  • Dividend Growth

    China SXT Pharmaceuticals does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.24% of the float of China SXT Pharmaceuticals has been sold short.
  • Short Interest Ratio / Days to Cover

    China SXT Pharmaceuticals has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in China SXT Pharmaceuticals has recently decreased by 54.81%, indicating that investor sentiment is improving significantly.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for China SXT Pharmaceuticals this week, compared to 0 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, China SXT Pharmaceuticals insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 3.95% of the stock of China SXT Pharmaceuticals is held by insiders.

  • Percentage Held by Institutions

    Only 5.02% of the stock of China SXT Pharmaceuticals is held by institutions.

  • Read more about China SXT Pharmaceuticals' insider trading history.
Receive SXTC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for China SXT Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

SXTC Stock News Headlines

Collect $7k per month from Tesla’s SECRET dividend
Tesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69% dividend from Tesla… Which could put up to $7,013 in your pocket every month…
China SXT Pharmaceuticals regains compliance with Nasdaq
China SXT Pharmaceuticals Inc trading resumes
China SXT Pharmaceuticals Inc trading halted, volatility trading pause
See More Headlines

SXTC Stock Analysis - Frequently Asked Questions

China SXT Pharmaceuticals' stock was trading at $4.0648 at the start of the year. Since then, SXTC shares have decreased by 40.0% and is now trading at $2.44.
View the best growth stocks for 2025 here
.

China SXT Pharmaceuticals shares reverse split before market open on Tuesday, February 25th 2025. The 1-8 reverse split was announced on Friday, February 21st 2025. The number of shares owned by shareholders was adjusted after the market closes on Monday, February 24th 2025. An investor that had 100 shares of stock prior to the reverse split would have 13 shares after the split.

Shares of SXTC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that China SXT Pharmaceuticals investors own include MARA (MARA), NIO (NIO), Meta Platforms (META), Alibaba Group (BABA), HEXO (HEXO), JD.com (JD) and Blink Charging (BLNK).

Company Calendar

Today
4/04/2025
Fiscal Year End
3/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:SXTC
Fax
N/A
Employees
90
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$1.82 million
Price / Cash Flow
N/A
Book Value
$30.46 per share
Price / Book
0.08

Miscellaneous

Free Float
3,902,000
Market Cap
$1.76 million
Optionable
Not Optionable
Beta
1.03
7 Top Nuclear Stocks To Buy Now Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (NASDAQ:SXTC) was last updated on 4/4/2025 by MarketBeat.com Staff
From Our Partners